Xueyuan Zeng

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [⁶⁸Ga]Ga-FAPI-RGD

Jie Zang, Xuejun Wen, Rong Lin et al. · Theranostics · 2022 · 76 citations · Full text

Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression

Xuejun Wen, Peng‐Fei Xu, Xinying Zeng et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 41 citations

Urology, Moderate Level, Radiation Therapy +9

PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect

Xuejun Wen, Xueyuan Zeng, Xingxing Cheng et al. · Molecular Pharmaceutics · 2022 · 29 citations

Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03

Xuejun Wen, Rongxi Wang, Peng‐Fei Xu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 17 citations

Translational Medicine, Gastrin-releasing Peptide Receptor, Integrin αVβ3 +7

Rational Design and Pharmacomodulation of ¹⁸F-Labeled Biotin/FAPI-Conjugated Heterodimers

Xuedong Chen, Dongsheng Xia, Xueyuan Zeng et al. · Journal of Medicinal Chemistry · 2024 · 13 citations